Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US NCI (National Cancer Institute) completes lung cancer trial enrolment:

This article was originally published in Clinica

Executive Summary

The National Cancer Institute has enrolled the hoped-for 50,000 persons into the National Lung Screening Trial to test whether early screening can reduce deaths from lung cancer. The participants - all current and former smokers with no apparent symptoms of lung cancer - will be screened with either spiral computed tomography or chest X-ray once a year for three years, and then be contacted annually until 2009. Although the full complement of participants has been enrolled, the trial will remain open at selected sites to collect blood, urine and sputum to help doctors identify biomarkers of lung cancer, said the research institute, which is working in partnership with the American Cancer Society.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057181

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel